DeJesus, E., Federico Andrade Villanueva, J., Ramon Arribas Lopez, J., Brinson, C., Crofoot, G., Daar, E. S., . . . Das, M. (2019). 318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials. Open Forum Infect Dis.
Citación estilo ChicagoDeJesus, Edwin, et al. "318. Tenofovir Alafenamide (TAF) Vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results From a Pooled Analysis of 7 Clinical Trials." Open Forum Infect Dis 2019.
Cita MLADeJesus, Edwin, et al. "318. Tenofovir Alafenamide (TAF) Vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results From a Pooled Analysis of 7 Clinical Trials." Open Forum Infect Dis 2019.